Are all clinical trial sites created equal?

Journal of the American College of Cardiology

Volumn 61, Issue 5, 2013, Pages 580-581

  Bhatt, Deepak L ^a,b   Cavender, Matthew A ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

acute heart failure; clinical trials; quality of care and outcomes assessment

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; INOTROPIC AGENT; TOLVAPTAN;

AGE; BLOOD PRESSURE; CARDIOLOGY; CARDIOVASCULAR MORTALITY; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EASTERN EUROPE; EVIDENCE BASED MEDICINE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GEOGRAPHY; HEART EJECTION FRACTION; HEART FAILURE; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LETTER; METHODOLOGY; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; NORTH AMERICA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POST HOC ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QRS COMPLEX; QUALITY CONTROL PROCEDURES; REPRODUCIBILITY; SAMPLE SIZE; SOUTH AMERICA; STUDY DESIGN; WESTERN EUROPE;

EID: 84873085286     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.10.024     Document Type: Editorial

References (14)

1. S.W. Glickman, J.G. McHutchison, E.D. Peterson Ethical and scientific implications of the globalization of clinical research N Engl J Med 360 2009 816 823
2. R.J. Little, R. D'Agostino, M.L. Cohen The prevention and treatment of missing data in clinical trials N Engl J Med 367 2012 1355 1360
3. J. Butler, H. Subacius, M. Vaduganathan Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial J Am Coll Cardiol 61 2013 571 579
4. M.A. Konstam, M. Gheorghiade, J.C. Burnett Jr. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 2007 1319 1331
5. R.P. Giugliano, J. Llevadot, R.G. Wilcox Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis Results from InTIME-II Eur Heart J 22 2001 1702 1715
6. C.M. O'Connor, M. Fiuzat, K. Swedberg Influence of global region on outcomes in heart failure beta-blocker trials J Am Coll Cardiol 58 2011 915 922
7. K.M. Akkerhuis, J.W. Deckers, E. Boersma Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes Results from PURSUIT Eur Heart J 21 2000 371 381
8. D.J. Kumbhani, C.P. Cannon, G.C. Fonarow Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes JAMA 302 2009 2207 2213
9. M. Gheorghiade, C. Orlandi, J.C. Burnett Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) J Card Fail 11 2005 260 269
10. P. Tricoci, J.M. Allen, J.M. Kramer, R.M. Califf, S.C. Smith Jr Scientific evidence underlying the ACC/AHA clinical practice guidelines JAMA 301 2009 831 841
11. G.M. Felker, K.L. Lee, D.A. Bull Diuretic strategies in patients with acute decompensated heart failure N Engl J Med 364 2011 797 805
12. V. Fuster, D.L. Bhatt, R.M. Califf Guided antithrombotic therapy: current status and future research direction: report on a national heart, lung and blood institute working group Circulation 126 2012 1645 1662
13. D.L. Bhatt Advancing the care of cardiac patients using registry data: going where randomized clinical trials dare not JAMA 303 2010 2188 2189
14. A.A. Bavry, D.L. Bhatt Interpreting observational studies - look before you leap J Clin Epidemiol 59 2006 763 764